Leptospirosis is a zoonotic disease that is highly prevalent in tropical countries; uveitis is one of the manifestations of leptospirosis. The leptospiral aetiology of uveitis is difficult to predict because of overlapping clinical symptoms with uveitis due to other causes. The objective of this study was to evaluate the leptospiral haemin-binding protein HbpA as a diagnostic antigen for the serodiagnosis of leptospiral uveitis. Serum samples from patients, clinically diagnosed with leptospiral uveitis, were tested by ELISA for anti-HbpA antibodies and compared against the 'gold standard' microscopic agglutination test (MAT). Non-leptospiral uveitis and normal healthy individuals were used as controls. A total of 60 serum samples from patients suffering from leptospiral uveitis were studied, obtained from Aravind Eye Hospital, Madurai. Anti-HbpA IgG antibodies were detected in 92 % of patients clinically diagnosed with leptospiral uveitis, indicating that it is more sensitive than MAT, which had a seropositivity of only 50 %, and better than the commercially available Pan Bio IgM ELISA (81 %). The mean anti-HbpA antibody titre was significantly higher in leptospiral uveitis patients compared with controls (P,0.05). The antigen showed negligible cross-reactivity with non-leptospiral uveitis samples and cataract controls. We conclude that HbpA IgG ELISA identified cases of uveitis with leptospirosis aetiology and proved to be useful in differentiating them from other forms of uveitis.
INTRODUCTION
Leptospirosis is a zoonotic disease caused by pathogenic spirochaetal bacteria belonging to the genus Leptospira. It is more prevalent in tropical countries, where the humid conditions favour the spread and transmission of the disease. Rodents and other wild animals and domestic animals serve as reservoirs of infection and shed live leptospires in their urine and contaminate the immediate environment. Humans become accidental hosts as a result of occupational and recreational activities; they are infected either by direct contact with infected animals or indirectly via contaminated water or soil.
The disease is grossly underreported because of its broad range of clinical manifestations, which range from mild flulike illness to the severe, often fatal form called Weil's disease. In the latter, fatality is often due to multiorgan failure including hepatorenal failure, myocarditis, severe pulmonary haemorrhage with respiratory distress and meningitis (Bharti et al., 2003) . Clinically, the disease presents with symptoms that mimic a number of other unrelated infections such as influenza, meningitis, hepatitis or dengue or viral haemorrhagic fevers. Uveitis is an important late complication (Rathinam, 2005) that occurs around 2-6 months after systemic disease. The onset and severity of leptospiral uveitis are quite variable, and the severity does not correlate with the severity of systemic disease. Common ocular signs include unilateral or bilateral, acute, non-granulomatous anterior or pan-uveitis, hypopyon, optic disc oedema, retinal vasculitis and membranous vitreous opacities (Rathinam, 2005) . Unlike systemic leptospirosis, leptospiral uveitis carries good prognosis.
The diagnosis of leptospirosis is based primarily on either isolation of the infecting organism or demonstration of a rise in the levels of anti-leptospiral antibodies in the serum of the infected subject. Culture is difficult and is usually not done and, conventionally, serological testing by microscopic agglutination test (MAT) is accepted as the gold standard. The latter, however, is time-consuming and has several disadvantages; it requires paired sera, especially in endemic areas, maintenance of several pathogenic serovars and trained personnel to perform the test (Faine et al., 1999) . Hence, there is a need to develop a simple, easy-to-perform immunoassay for the detection of antibodies against pathogen-specific leptospiral antigens expressed in vivo. ELISAs based on whole-cell leptospiral antigen preparations (Terpstra et al., 1985; McBride et al., 2007) LipL32 (Haake et al., 2000; Smits, 2005) , LipL41 and OmpL1 (Natarajaseenivasan et al., 2008) , Hsp58 (Park et al., 1999) , Lig proteins (Croda et al., 2007) , LruA and LruB (Verma et al., 2008) have been developed in order to detect leptospiral infection in humans.
In a previous study, we identified a haemin-binding, TonBdependent outer-membrane protein, HbpA (Sritharan et al., 2005; Asuthkar et al., 2007) , in pathogenic Leptospira species. HbpA is an 81 kDa protein expressed upon limitation of iron. The mammalian host limits iron to an invading pathogen as part of its innate immune response (Kochan, 1977) and therefore the expression of the protein, as inferred from the presence of anti-HbpA antibodies, is not surprising (Sridhar et al., 2008) . We demonstrated the diagnostic potential of HbpA in screening for leptospirosis (Sridhar et al., 2008; Sivakolundu et al., 2011) and here we extend the usefulness of HbpA IgG ELISA to the serological diagnosis of clinically confirmed cases of leptospiral uveitis that were negative by MAT.
METHODS
Subjects. The human subjects included in this study are detailed in Table 1 and include patients (and contacts) attending the Uvea Clinic, Aravind Eye Hospital, Madurai. Leptospiral strains. Leptospiral reference strains (Table 2) were obtained from the Royal Tropical Institute (KIT), Amsterdam, The Netherlands. They were maintained in semi-solid (0.15 % agar) and liquid EMJH medium.
MAT. All serum samples were screened by MAT using a panel of 20 serovars of Leptospira species (Table 2 ). The end point was taken as the highest dilution of the serum in which 50 % of the organisms were agglutinated or in which there was a 50 % reduction in the number of organisms compared with the control. Titres ¢1 : 100 were considered as positive (Terpstra et al., 1985; Priya et al., 2003) .
Recombinant HbpA and anti-HbpA antibodies. Recombinant HbpA (rHbpA) and anti-HbpA antibodies were prepared as reported previously (Asuthkar et al., 2007) . The polyclonal antibodies were tested for cross-reactivity against whole-cell sonicates of Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 29213, Pseudomonas aeruginosa ATCC 27853, Proteus vulgaris, Klebsiella pneumoniae (collection of the L. V. Prasad Eye Institute, Hyderabad, India) and Mycobacterium tuberculosis ATCC 27294. Aliquots (500 ng) of these cell-free sonicates were coated on polystyrene microtitre plates (Corning) and incubated with anti-HbpA antibodies (1 : 100 dilution) for 2 h, followed by the addition of goat anti-rabbit IgG alkaline phosphatase conjugate (1 : 5000 dilution; Bangalore Genei). The alkaline phosphatase substrate p-nitrophenyl phosphate (100 ml; Bio-Rad) was added and incubated for 15 min and the absorbance was read at 405 nm in an ELISA reader (model 680XR; Bio-Rad). Purified rHbpA (100 ng) and whole-cell sonicates of Leptospira interrogans serovar Manilae, grown under high-and low-iron conditions (Asuthkar et al., 2007) , were included as controls. The experiment was repeated three times with each reaction set up in duplicate.
HbpA IgG ELISA. Optimal antigen concentration and serum dilution were determined by chequerboard titration using a known positive serum sample, according to published protocols (Sivakolundu et al., 2011) . Briefly, flat-bottomed polystyrene microtitre plates (Corning) were coated with 250 ng rHbpA (100 ml in 0.1 M bicarbonate buffer, pH 9.2) for 3 h at 37 uC, followed by overnight incubation at 4 uC. The plates were washed three times with 10 mM PBST (0.01 M phosphate buffer, pH 7.4, with 0.05 % Tween 20 and 0.9 % NaCl) and (3), sympathetic ophthalmia (2), unilateral granulomatous pan-uveitis with tractional retinal detachment (1), sarcoid uveitis (1), Fuch's heterochromic uveitis (6), bilateral granulomatous uveitis (1) and HLA B27-related uveitis (1).
then blocked with 5 % (w/v) BSA in PBST for 2 h at 37 uC, and then 100 ml human serum sample (1 : 200 dilution) was added and incubated for 2 h at 37 uC. After washing, the plates were incubated for 2 h at 37 uC with 100 ml rabbit anti-human IgG alkaline phosphatase conjugate (1 : 5000 dilution; Bangalore Genei). Substrate was added and the absorbance was read as described above. Antigen and antibody blanks were included in the test to check for background absorbance. A known positive serum sample and a serum sample from a healthy individual were used as positive and negative controls, respectively.
Commercial Pan Bio IgM ELISA. All the test serum samples were tested for anti-leptospiral antibodies with the commercial Pan Bio Leptospira IgM ELISA kit (Inverness Medical Innovations Australia). Serum (100 ml, diluted 1 : 100) was added to the pre-coated microwell strip. Plates were incubated at 37 uC for 30 min and then washed and 100 ml peroxidase-conjugated anti-human IgM was added, followed by incubation for 30 min at 37 uC. After sufficient washes to remove the unbound conjugate, 100 ml tetramethyl benzidine/hydrogen peroxide was added and the plates were incubated for 10 min. The reaction was stopped by the addition of 100 ml 1 M phosphoric acid and the absorbance was read at 450/600 nm using an ELISA reader (model 680XR; Bio-Rad). The cut-off value was calculated by multiplying the mean absorbance of the calibrator sample replicates with the calibration factor (according to the manufacturer's instructions). The Pan Bio unit for each sample was calculated by dividing the absorbance of the sample by the cut-off value and then multiplying by 10. A score ,9 units indicated a negative result, 9-11 units an equivocal result and .11 units a positive result, indicating the presence of leptospira-specific IgM antibodies.
Statistical analysis. Data were analysed using the SPSS version 13 statistical package (SPSS Inc. 
RESULTS

MAT
All the serum samples included in the study were screened for anti-leptospiral antibodies by MAT; 50 % of the leptospiral uveitis cases were negative by MAT. Icterohaemorrhagiae was identified to be the predominant infecting serogroup in both systemic leptospirosis (30 %) and leptospiral uveitis (35 %) patients. The other major infecting serogroups were Autumnalis, Australis, Louisiana and Pyrogenes (Table 3) . Groups III, IV and V, representing non-leptospiral uveitis, cataract and normal healthy controls, tested negative by MAT.
HbpA IgG ELISA
Characterization of anti-HbpA antibodies Analysis of polyclonal HbpA antibodies for cross-reactivity against other bacterial whole-cell sonicates revealed low levels of reactivity (A 405 ,0.2). A threefold increase in the absorbance was observed with the sonicate from L. interrogans serovar Manilae grown under low-iron conditions (A 405 0.633± 0.016) in comparison with high-iron conditions (A 405 0.229 ±0.013), with maximal reactivity (A 405 2.380±0.08) observed with purified rHbpA protein (Fig. 1) .
HbpA IgG ELISA Based on the mean absorbance plus two standard deviations of the group V healthy controls, the cut-off value was established as 0.376. A significant increase in antibody levels was observed in the serum of group I leptospiral uveitis patients compared with controls (P,0.05) in both MAT-positive (93 % positive) and MAT-negative (90 %) cases included in group I (Fig. 2 , Table 4 ). Similarly, the levels of antibodies among systemic leptospirosis patients were also significantly higher compared with controls (P,0.05). Low levels of antibodies above the cut-off value were identified in three nonleptospiral uveitis patients and three cataract controls. 
DISCUSSION
Uveitis refers to inflammation of the uvea or the middle layer of the eye. The aetiology of the disease is multifold and, among the infectious agents, pathogenic leptospires contribute to ocular inflammation in humans (Rathinam, 2005) . Ocular manifestations are commonly seen in leptospiral infections. Of the individual ocular signs, the combination of acute, non-granulomatous pan-uveitis, hypopyon, vasculitis, optic disc oedema, membranous vitreous opacities and absence of choroiditis or retinitis has a high predictive value for the clinical diagnosis of leptospiral uveitis. There is a need for a diagnostic test to distinguish leptospiral uveitis from other types of uveitis.
In this study, we report the diagnostic potential of the haemin-binding protein HbpA in the identification of leptospiral uveitis. This study was done on patients attending the Uvea Clinic in Aravind Eye Hospitals, Madurai, one of the leading eye hospitals in India.
HbpA was first reported as an iron-regulated, haeminbinding protein in serovar Lai (Sritharan et al., 2005; Asuthkar et al., 2007) . Its absence from non-pathogenic Leptospira species and the in vivo expression of the protein, coupled to its usefulness in screening of clinical isolates by PCR (Sridhar et al., 2008) and ELISA (Sivakolundu et al., 2011) , led us to extend its usefulness to the diagnosis of leptospiral uveitis. Recombinant HbpA was prepared as described previously (Asuthkar et al., 2007) and we showed that there are no epitopes in the protein that are shared with other bacterial proteins. There was low crossreactivity with other TonB-dependent proteins within the same organism, as reflected by the low reactivity of the leptospiral extract of L. interrogans serovar Manilae grown under high-iron conditions; a threefold increase was seen in extracts of low-iron-grown organisms as a result of increased expression of HbpA.
As this region of India is endemic for the disease, a baseline titre was determined for ELISA-based detection of IgG antibodies against HbpA and a cut-off was established from the data obtained from normal healthy controls (group V). The endemic nature of the disease accounts for the values observed in groups III, IV and V. Sera from all five groups were tested by the conventional 'gold standard' MAT. The predominant infecting serogroups (Icterohaemorrhagiae, Australis and Autumnalis) in MAT-positive leptospiral uveitis (group I) were similar to those reported for systemic leptospirosis patients, in agreement with our earlier reports (Priya et al., 2003 (Priya et al., , 2007 . Patients with systemic leptospirosis (group II), all of whom were MATpositive, showed high levels of anti-HbpA IgG antibodies, as expected. Interestingly, 92 % of the patients clinically identified as having leptospiral uveitis (group I) showed significantly high levels of anti-HbpA antibodies (Fig. 2) compared with controls (P,0.05), though 50 % of them were found to be MAT-negative. The failure of MAT to identify all clinically proven cases of leptospiral uveitis, as seen in this study and in an earlier study (Priya et al., 2003) , both showing a low specificity of 58 %, indicates strongly that MAT cannot be used as the gold standard for diagnosis of leptospiral uveitis, as is currently being done (15) for systemic leptospirosis. There are also reports of the low sensitivity of MAT in diagnosing the latter, even at the optimal stage of systemic leptospiral infection (Limmathurotsakul et al., 2012; Goris et al., 2012) . Agglutination of live organisms in MAT is due predominantly to the presence of antibodies against the highly antigenic lipopolysaccharide determinants that are specific to each serovar. In fact, this was the basis of the older classification of Leptospira into serogroups and serovars, based on their antigen-relatedness (Bharti et al., 2003) . Thus, the failure to detect those serovars prevalent in a particular geographical region can be attributed to their omission from the reference panel of live organisms used for the test. This could therefore account for the MAT-negativity in group I in this study; low levels of leptospira-specific antibodies at the late convalescent phase could also account for the failure to detect by MAT.
The failure of MAT to identify more than 50 % of clinically positive cases of suspected leptospiral uveitis led us to confirm the leptospiral aetiology using the commercial Pan Bio IgM ELISA. The MAT-negative patients identified clinically as patients with leptospiral aetiology because of the presence of pathognomonic clinical signs specific for leptospiral uveitis were positive both by HbpA IgG ELISA and the commercial Pan Bio IgM ELISA ( (Winslow et al., 1997; Bajani et al., 2003) , it has limited application in the diagnosis of leptospiral uveitis in this geographical region.
The observations in this study have strengthened the diagnostic potential of HbpA for the screening of leptospirosis. The in vivo expression of HbpA and its presence only in pathogenic Leptospira species make it an ideal diagnostic antigen. The upregulation of HbpA by iron limitation and rise in temperature (Asuthkar et al., 2007) , encountered within the mammalian host, would therefore reflect active infection. In this study, HbpA IgG ELISA proved to be useful in the screening of cases of not only systemic leptospirosis but also leptospiral uveitis. The simple format of ELISA would be suitable for use in routine laboratories and would be cost-effective when compared with MAT and PCR. ELISA is a better alternative to MAT as it does not require live pathogenic cultures, can achieve high sensitivity and specificity and can be semi-automated. The results can be interpreted objectively and the analysis can be done in small laboratories without the need for any specialized equipment. The assay is rapid and the antigen-coated plates can be stored and used at any time of the year, unlike MAT, where the organisms have to be grown and monitored continuously so that they are in exponential phase for analysis. MAT may be useful in epidemiological studies for identifying the predominant serovar, but timely diagnosis of the leptospiral aetiology by HbpA IgG ELISA, irrespective of the infecting serovar, followed by the timely treatment of the disease will contribute to better control measures. Secondly, HbpA IgG ELISA will be simpler to use and more economical than hbpA PCR. Earlier, using primers specific for hbpA in the genome of serovar Lai, we identified all the serovars belonging to L. interrogans by PCR. While specific primers can now be designed from the increasingly available whole genome sequence data in order to identify other species (Bulach et al., 2006) , PCR may not be economically viable as a routine diagnostic test and, because of the inherent problem of false positivity, cannot be used as the sole diagnostic test. HbpA IgG ELISA therefore offers considerable promise for the screening of both systemic leptospirosis and leptospiral uveitis. 
